Evolution from Gene Discovery to Drug Development
Howard Chang, a renowned genomic researcher and dermatologist, transitioned from academia and biotech startups to become Amgen's new CSO, focusing on genetic target discovery, extrachromosomal DNA, and technology development to advance drug discovery.